Translational Immunology, D015, German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.
Translational Immunology, D015, German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.
Semin Cancer Biol. 2014 Oct;28:51-7. doi: 10.1016/j.semcancer.2014.04.008. Epub 2014 Apr 24.
The immune system of cancer patients is often suppressed. Accumulating evidence suggests that exosomes released from tumor cells may play an essential role in this process but the mechanisms are not fully understood. Here we review recent papers showing that exosomes trigger the release of cytokines/chemokines from immune cells. We suggest that this process will either result in the stimulation of anti-tumor immune reactions or in a systemic immunosuppression. The direction appears to be largely dependent on the duration of interactions between immune cells and exosomes leading to the accumulation of inflammatory factors, i.e. on the length of the exposure to these factors. We propose that a long-term interaction of the immune system with elevated levels of tumor exosomes contributes to the development of immunosuppression in cancer patients.
癌症患者的免疫系统通常受到抑制。越来越多的证据表明,肿瘤细胞释放的外泌体可能在这一过程中发挥重要作用,但具体机制尚不完全清楚。在这里,我们回顾了最近的一些论文,这些论文表明外泌体触发了免疫细胞释放细胞因子/趋化因子。我们认为,这个过程将导致抗肿瘤免疫反应的刺激或全身性免疫抑制。这一方向在很大程度上似乎取决于免疫细胞与外泌体相互作用的持续时间,从而导致炎症因子的积累,即这些因子暴露的时间长短。我们提出,免疫系统与高水平肿瘤外泌体的长期相互作用导致癌症患者免疫抑制的发展。